Enduring Material

• Discuss the basics of the neurobiology of addiction.
• Identify the differences between medications for opioid use disorder.
• Describe the diagnosis, intake, buprenorphine induction of a patient with OUD.
• Identify how to manage acute and chronic pain for patients with opioid use disorder with a specific emphasis on using buprenorphine for pain management
• Describe key principals in management of patients with OUD
• Recognize harm reduction strategies and how stigma can affect care for patient's with SUD

• MyMichigan Health designates this enduring material for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
• MyMichigan Health designates this enduring material for a maximum of 4 Hour(s) Attendance w/ No Credit. Participants should claim only the credit commensurate with the extent of their participation in the activity.

Jonathan Morrow, MD and Sheba Sethi, MD have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.

Sheba Sethi, MD has indicated the presentation may include discussion of any off-label uses of a product. Explanation Given: We will discuss using buprenorphine-naloxone off label for pain management in the event insurance will not cover the FDA-approved bupe formulations for pain and/or the patient also has OUD.

• MyMichigan Health is accredited by The Michigan State Medical Society to provide continuing medical education for physicians.

100 %

10/6/2023